8 October 2025 A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their ...

Regeneron and Bayer suffered a UK setback as the court followed others in Europe in its interpretation of the so-called SPC ...

14 November 2025 In-house counsel from AstraZeneca, BAT and Novartis say that investing in AI now will pay off in time saved, ...

A regulatory counsel with nine years at the FDA and over two decades of patent experience at a US law firm in Washington DC, ...

The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke. Already ...

The week has exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated ...

The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader. Already registered? If you don't ...

11 November 2025 Partnering with AI vendors can open doors for startups and small companies but it also brings serious risks.

22 September 2025 The pharma giant invalidates a university's patent while gaining FDA approval for a new subcutaneous ...

President-elect Deborah Hampton says she is looking forward to advancing the association’s advocacy work in the new year, and implementing its 2026–2029 plan. Already registered?

22 October 2025 The Supreme Court’s 2023 Amgen ruling turned patent strategy upside down. Now lawyers are rethinking ...